Health Minister Kwabena Mintah Akandoh Spearheads Reforms for Pharmaceutical Sovereignty and Supply Chain Safety

Minister for Health Kwabena Mintah Akandoh has unveiled a comprehensive strategy to transform Ghana’s pharmaceutical landscape, focusing on both the immediate safety of the medical supply chain and the long-term goal of achieving "pharmaceutical sovereignty." Addressing Parliament and industry stakeholders, the Minister detailed new regulatory measures designed to ensure that all medical products distributed within the country meet rigorous international standards. This dual-pronged approach aims to protect public health through stricter oversight while simultaneously building a resilient local industry capable of meeting domestic needs without heavy reliance on foreign imports.

Central to this initiative is the enforcement of the Public Health Act, 2012 (Act 851), which mandates the licensing of storage facilities under the supervision of the Food and Drugs Authority (FDA). Minister Akandoh emphasized that Ghana’s storage and distribution guidelines are now fully aligned with World Health Organization (WHO) recommendations. To ensure compliance, the government is facilitating continuous training for pharmacists, healthcare providers, and logistics personnel on Good Storage and Distribution Practices. These measures are expected to enhance transparency and efficiency, ensuring that quality-assured medicines reach every corner of the country.

Beyond logistics, the government is collaborating with the Pharmaceutical Manufacturers Association of Ghana (PMAG) to accelerate local production and innovation. At a recent industry conference in Accra, stakeholders underscored the urgency of reducing dependence on imported medicines—a vulnerability starkly exposed during the COVID-19 pandemic. To drive this transition, the Ministry of Health is implementing a National Pharmaceutical Policy and exploring the creation of a Pharmaceutical Industrial Park. Additionally, the proposed Ghana Pharma Innovation Fund is being discussed to provide the necessary financial and technical support to foster domestic research, despite challenges such as high operational costs and the current dependence on imported raw materials.

These domestic efforts align with a broader continental push for health security led by the Africa CDC. Director-General Jean Kaseya has recently advocated for increased self-sufficiency across African nations, urging countries to leverage their manufacturing capabilities to manage health crises and secure sovereignty over health data. By strengthening its regulatory frameworks and manufacturing base, Ghana is positioning itself as a key player in this regional movement. Minister Akandoh remains optimistic that these reforms will result in a more resilient, efficient, and accessible healthcare delivery system for all Ghanaians.